Rainey & Randall Wealth Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$311K Buy
1,236
+2
+0.2% +$430 0.04% 61
2026
Q1
$268K Buy
1,234
+1
+0.1% +$222 0.04% 61
2025
Q4
$282K Buy
1,233
+1
+0.1% +$228 0.05% 62
2025
Q3
$285K Buy
1,232
+2
+0.2% +$407 0.05% 62
2025
Q2
$228K Buy
1,230
+2
+0.2% +$372 0.04% 68
2025
Q1
$257K Buy
+1,228
New +$239K 0.05% 63

Other funds holding ABBV

Rainey & Randall Wealth Advisors's ABBV Position: Q2 2026 in Review

Rainey & Randall Wealth Advisors increased its AbbVie (ABBV) stake by 0.16% in Q2 2026, buying an estimated $430 and bringing the position to 1,236 shares worth $311K. The position accounts for 0.04% of the portfolio, ranked #61.

Rainey & Randall Wealth Advisors first reported a position in ABBV in Q1 2025 and has held it in 6 quarters since. 4,190 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Rainey & Randall Wealth Advisors held 1,236 shares of AbbVie worth $311K as of Q2 2026.
  • Rainey & Randall Wealth Advisors bought 2 AbbVie shares in Q2 2026, an estimated $430.
  • AbbVie made up 0.04% of Rainey & Randall Wealth Advisors's portfolio in Q2 2026, its #61 holding.
  • Rainey & Randall Wealth Advisors first reported a position in AbbVie in Q1 2025 and has held it in 6 quarters since.
  • 4,190 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Rainey & Randall Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.